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ABSTRACT
Background: Common features of allergic or atopic ocular and skin diseases are the participation of Th2 lym-
phocytes and eosinophils and colonization by Staphylococcus aureus. To examine the role of interaction be-
tween Th2 cells and bacterial infection in tissue eosinophilia, we determined the effects of Th2 cytokines and
peptidoglycan derived from the cell wall of S. aureus on corneal fibroblasts.
Methods: Chemokine concentrations and the cell surface expression of adhesion molecules were determined
by ELISAs, and chemokine and adhesion molecule mRNAs were quantitated by real-time PCR analysis. Sig-
naling by the transcription factor NF-κB was evaluated by immunoblot and immunofluorescence analyses as
well as by assay of DNA binding activity.
Results: Among Th2 cytokines tested, only interleukin (IL)-4 and IL-13 induced a low level of eotaxin release
by corneal fibroblasts, as did peptidoglycan. However, the combination of peptidoglycan and either IL-4 or IL-13
induced a marked synergistic increase both in eotaxin release (without affecting that of IL-8) and in the abun-
dance of eotaxin mRNA. The combination of peptidoglycan and IL-4 or IL-13 also synergistically increased the
surface expression of VCAM-1, but not that of ICAM-1. Peptidoglycan activated NF-κB in corneal fibroblasts,
and inhibitors of NF-κB attenuated eotaxin release induced by peptidoglycan alone or in combination with IL-4
or IL-13.
Conclusions: Interaction of innate and adaptive immunity, as manifested by synergistic stimulation of eotaxin
and VCAM-1 expression in corneal fibroblasts by peptidoglycan and Th2 cytokines, may play an important role
in tissue eosinophilia associated with ocular allergy.
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INTRODUCTION
The Th2 immune system, mediated in part by Th2 cy-
tokines such as IL-4 and IL-13, plays a central role in
the pathogenesis of allergic diseases such as asthma,
atopic dermatitis, and ocular allergic diseases.1 An-
other hallmark of these diseases is tissue eosino-
philia. The C-C chemokine eotaxin (CCL11) is a po-
tent and selective chemoattractant for eosinophils
and contributes to tissue-specific eosinophil recruit-
ment in allergic diseases.2 Although the sources and
regulation of eotaxin production remain incompletely
characterized, we and others have shown that resi-
dent fibroblasts activated by Th2 cytokines are a po-
tential major source of eotaxin in tissue affected by al-
lergic diseases.3-5
Eosinophils express the adhesion molecule VLA-4,
which binds to VCAM-1 expressed on endothelial and
other cell types.6 We have shown that the inhibition
of the VLA-4-VCAM-1 interaction in vivo suppressed
allergen-induced infiltration of eosinophils into the
conjunctiva in mouse model of allergic conjunctivitis.7
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Characterization of the regulation of eotaxin and
VCAM-1 expression is therefore likely to provide in-
sight into the mechanisms that underlie the local ac-
cumulation of eosinophils in allergic inflammation.
The Gram-positive bacterium Staphylococcus aureus
colonizes the skin of individuals with atopic eczema,
and the skin of patients with atopic dermatitis has
been shown to exhibit an increased avidity for S.
aureus and to be deficient in the ability to produce an-
timicrobial peptides that contribute to the eradication
of infectious agents.8 The ocular surface is also com-
monly affected by infectious diseases and allergic re-
actions, given that it is continuously exposed to a vari-
ety of airborne bacteria and antigens. Several clinical
forms are included in the classification of allergic ocu-
lar surface diseases including seasonal or perennial
allergic conjunctivitis, vernal keratoconjunctivitis,
atopic keratoconjunctivitis (AKC), and giant papillary
conjunctivitis. AKC is severe type of ocular allergy
and is defined as a chronic allergic inflammation of
the ocular surface including, conjunctiva, eyelids, and
cornea, affecting individuals with a history of atopic
dermatitis.9 In addition to allergic inflammation, com-
plications of AKC also include S. aureus and herpes
simplex infection of ocular surface in some patients.
Indeed, high rates of bacterial colonization, especially
with S. aureus, have thus been demonstrated in the
conjunctival sacs and eyelid margins as well as on the
skin of individuals with atopic dermatitis.10 Toll-like
receptors (TLRs) comprise a family of cell surface
proteins in mammals that play an important role in in-
nate immune responses by stimulating the produc-
tion of proinflammatory cytokines in response to vari-
ous microbial ligands.11 TLR4 thus recognizes LPS, a
component of Gram-negative bacteria, whereas TLR2
mediates responses to lipoteichoic acid, lipopeptides,
and peptidoglycan (PGN) of Gram-positive bacteria
and mycobacteria. Corneal fibroblasts and epithelial
cells express various TLRs for microbial ligands.12,13
Cell wall components of S. aureus might thus also be
expected to activate tissue-resident cells, but the role
of PGN in allergic diseases has remained unknown.
Corneal involvement secondary to severe conjunc-
tival allergic inflammation is the most serious compli-
cation of AKC. The expression of eotaxin and adhe-
sion molecules by corneal fibroblasts but not corneal
epithelial cells likely contributes to the formation of
corneal lesions by promoting the local infiltration, ac-
tivation, and survival of eosinophils.14,15 Corneal epi-
thelial cells thus do not express chemokines in re-
sponse to Th2 cytokines but rather likely act as a bar-
rier not to penetrate inflammatory mediators into the
stroma. Mechanical compression as well as inflamma-
tory mediators may disrupt the barrier function of
corneal epithelial cells during allergic inflammation.
Indeed, corneal epithelial barrier function is impaired
in individuals with atopic blepharoconjunctivitis.16 In
addition, we have recently shown that the loss of the
barrier function of the corneal epithelium exacer-
bated conjunctival inflammation in a rat model of ocu-
lar allergy.17 We have also reported that restoration
of the corneal epithelium resulted in amelioration of
conjunctival inflammation in a case of AKC.18 Taken
together, these reports suggest that the vicious cycle
between conjunctival inflammation and corneal le-
sions is mediated by the activation of corneal fibro-
blasts.
Given the increased rate of ocular infection with S.
aureus and the role of Th2 cytokines in AKC and
atopic dermatitis, we hypothesized that the innate
and adaptive immune systems might cooperate to ac-
tivate resident cells such as fibroblasts at the site of
allergic inflammation. To explore this possibility, we
examined the effects of exposure of corneal or der-
mal fibroblasts to the combination of PGN and Th2
cytokines on the expression of eotaxin and VCAM-1
at the mRNA and protein levels.
METHODS
MATERIALS
MEM, FBS, PBS, and trypsin-EDTA were obtained
from Gibco-BRL (Grand Island, NY, USA), and cell
culture dishes (Falcon) were from Becton Dickinson
(Franklin Lakes, NJ, USA). PGN of S. aureus was
from Fluka (St. Louis, MO, USA). Human recombi-
nant cytokines, paired antibodies to eotaxin or to IL-8,
as well as human eotaxin and IL-8 standards for ELI-
SAs were from R&D Systems (Minneapolis, MN,
USA). A Reverse Transcription System was from
Promega (Madison, WI, USA), and a QuantiTect
SYBR Green PCR kit was from Qiagen (Hilden, Ger-
many). Rabbit polyclonal Abs to IκB-α and to the p65
subunit of NF-κB, normal rabbit or mouse IgG, and
HRP-conjugated goat Abs to rabbit IgG were from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). A
mouse mAb to VCAM-1 was from Pharmingen (San
Diego, CA, USA), and HRP-conjugated goat Abs to
mouse IgG were from Chemicon (Temecula, CA,
USA). ECL immunoblot detection reagents and Hy-
perfilm were from Amersham Pharmacia Biotech
(Little Chalfont, UK). Alexa488-conjugated goat Abs
to rabbit IgG were from Molecular Probes (Eugene,
OR, USA). The pyrrolidine derivative of dithiocar-
bamate (PDTC) and actinomycin D were from Sigma
(St. Louis, MO, USA), N-tosyl-L-phenylalanine chlo-
romethyl ketone (TPCK) was from Wako Pure
Chemical Industries (Osaka, Japan). All reagents
used for cell culture were endotoxin minimized.
CELL CULTURE AND INCUBATION FOR MEAS-
UREMENT OF CHEMOKINE RELEASE
Human corneal fibroblasts were isolated as described
previously.3,19 The human tissue was used in strict ac-
cordance with the basic principles of the Declaration
of Helsinki. Normal human dermal fibroblasts were
obtained from Cascade Biologics (Portland, OR,
Eotaxin and VCAM-1 in Corneal Fibroblast
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USA) or Clonetics (Walkersville, MD, USA). Cells
were seeded in 24-well culture plates and cultured for
3 days in MEM supplemented with 10% FBS. They
were then washed with PBS, cultured for 24 h in
MEM without added serum, and then incubated for
the indicated times in the same medium supple-
mented with PGN or cytokines. The medium was
then collected and centrifuged at 120 × g for 5 min,
and the resulting supernatant was stored at -80℃ for
subsequent assay of chemokines. The fibroblasts re-
maining in each well were exposed to trypsin-EDTA,
and their number was determined with a hemocy-
tometer.
DETERMINATION OF CHEMOKINE CONCEN-
TRATION BY ELISA
The concentration of chemokines in culture superna-
tants was determined in quadruplicate with solid-
phase ELISAs. The limit of detection for both eotaxin
and IL-8 was 3.9 pgml, and data are presented as
nanograms of chemokine per 1 × 106 cells.
QUANTITATIVE RT-PCR ANALYSIS OF EOTAXIN
AND VCAM-1 mRNAs
The abundance of eotaxin and VCAM-1 mRNAs was
determined by RT and quantitative real-time PCR
analysis as described previously.20,21 In brief, total
RNA was extracted from fibroblasts and subjected to
RT, and the resulting cDNA was then subjected to
real-time PCR with a LightCycler instrument (Roche
Molecular Biochemicals, Indianapolis, IN, USA).
Transcripts of the constitutively expressed gene for
GAPDH served to normalize the amount of target
mRNA in each sample. The sequences of the PCR
primers for eotaxin, VCAM-1, and GAPDH were de-
scribed previously.20,21 Real-time PCR data were ana-
lyzed with LightCycler software 3.01 (Roche Molecu-
lar Biochemicals).
IN SITU WHOLE-CELL ELISA FOR VCAM-1 AND
ICAM-1
An in situ whole-cell ELISA for VCAM-1 and ICAM-1
was performed as described.21 Cells were seeded in
96-well culture plates and cultured and incubated as
for measurement of chemokine release. After incuba-
tion with PGN or cytokines for 24 h, the cells were
washed twice with PBS, fixed for 15 min at room tem-
perature with PBS containing 1% paraformaldehyde,
washed with PBS containing 0.1% BSA, and incubated
for 1 h at 37℃ with a mAb to VCAM-1 or ICAM-1 (1 :
10,000 dilution) in PBS-BSA (1%). After washing
three times with PBS-BSA (0.1%), the cells were incu-
bated for 1 h at 37℃ with HRP-conjugated goat Abs
to mouse IgG in PBS-BSA (1%), washed three times
with PBS-BSA (0.1%), and then incubated for 20
min in the dark with 100 μl of 3,3’5,5’-tetramethyl-
benzidine solution. The reaction was terminated by
the addition of 50 μl of 1 M H2SO4, and the absor-
bance of each well was measured at 450 nm with a
microplate reader.
IMMUNOBLOT ANALYSIS OF IκB-α
The degradation of IκB-α in corneal fibroblasts was
examined by immunoblot analysis as described previ-
ously.22 In brief, cells were incubated for various
times at 37℃ with MEM containing PGN (30 μgml),
washed twice, and then lysed with RIPA buffer. Cell
lysates (20 μg of protein) were subjected to SDS-
PAGE on a 10% gel under reducing conditions, and
the separated proteins were then transferred electro-
phoretically to a polyvinylidene difluoride membrane.
After blocking of nonspecific sites, the membrane
was incubated with rabbit polyclonal Abs to IκB-α,
and immune complexes were detected with HRP-
conjugated secondary Abs and ECL reagents.
IMMUNOFLUORESCENCE ANALYSIS OF NF-κB
Immunostaining of NF-κB in corneal fibroblasts was
performed as described previously.23 In brief, cell
monolayers grown on eight-well chamber slides were
cultured for 24 h at 37℃ in serum-free MEM, incu-
bated for various times at 37℃ with MEM in the ab-
sence or presence of PGN (30 μgml), washed twice
with PBS, and fixed with 4% paraformaldehyde in
PBS. After three additional washes, the cells were
permeabilized with 100% methanol at -20℃ for 6 min,
and nonspecific adsorption of antibodies was blocked
by incubation of the cells for 30 min at room tempera-
ture with PBS containing 3% BSA. The cells were
then incubated for 1 h at room temperature with Abs
to the p65 subunit of NF-κB (1:100 dilution in PBS
containing 1% BSA), washed, and incubated for 30
min at room temperature with Alexa488-conjugated
secondary Abs (1:500 dilution in PBS containing 1%
BSA). They were finally washed, mounted in Vec-
tashield mounting medium, and examined with a fluo-
rescence microscope (Axiovert; Carl Zeiss, München-
Hallbergmoos, Germany).
ASSAY OF DNA BINDING ACTIVITY OF NF-κB
p65
Binding of NF-κB to κB sites was assessed with the
use of a Trans-AM NF-κB p65 assay kit (Active Motif,
Rixensart, Belgium). In this assay, an oligonucleotide
containing the NF-κB consensus site is attached to
the wells of a 96-well plate, and binding of the active
form of NF-κB present in nuclear extracts to this oli-
gonucleotide is detected with ELISA technology.24
Cells were stimulated for 60 min with PGN (30 μg
ml), or with TNF-α (10 ngml) as a positive control,
and nuclear extracts were then prepared. Portions of
the extracts (8 μg of protein) were then analyzed for
p65 binding to the κB oligonucleotide. The specificity
of the assay was monitored on the basis of competi-
tion with free wild-type κB oligonucleotide or a mu-
tated κB oligonucleotide.
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Fig.　1　Effects of PGN, IL-4, and IL-13 on eotaxin release by human corneal fi broblasts. (A) Cells were cultured for 24 h with 
the indicated concentrations of PGN in the absence (circles) or presence of IL-4 (closed triangles) or IL-13 (open triangles) 
each at a concentration of 10 ng/ml. (B, C) Cells were cultured for 24 h with the indicated concentrations of IL-4 (B) or IL-13 
(C) in the absence (open circles) or presence (closed circles) of PGN (30 μg/ml). (D) Cells were cultured for the indicated 
times in the presence of PGN (30 μg/ml) and either IL-4 (closed circles) or IL-13 (open circles), each at a concentration of 10 
ng/ml. Culture supernatants from all incubations were assayed for eotaxin by ELISA. Data are means +_ SEM of values from 
four separate experiments. *p < 0.05, **p < 0.01 (Dunnett’s test) versus the corresponding value for cells incubated in the ab-
sence of PGN or cytokine.
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Fig.　2　Effects of PGN and Th2 cytokines on eotaxin and IL-8 release by human corneal and skin fi broblasts. Fibroblasts 
derived from the cornea (A, B) or skin (C, D) were incubated for 24 h with the indicated Th2 cytokines (10 ng/ml) in the ab-
sence (open bars) or presence (closed bars) of PGN (30 μg/ml), after which the concentration of eotaxin (A, C) or IL-8 (B, D) 
in the culture supernatants was measured by ELISA. Data are means +_ SEM of values from four separate experiments. *p < 
0.0001 (Dunnett’s test) versus the corresponding value for cells incubated in the absence of cytokine.
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STATISTICAL ANALYSIS
Data are presented as means ± SEM. Results were
compared between two groups with the unpaired Stu-
dent’s t test and among three or more groups by Dun-
nett’s test. Statistical analyses were performed with
StatView for Windows software (version 5.0; SAS In-
stitute, Cary, NC, USA). A p value of <0.05 was con-
sidered statistically significant.
RESULTS
EFFECTS OF PGN AND Th2 CYTOKINES ON
EOTAXIN RELEASE IN HUMAN CORNEAL AND
DERMAL FIBROBLASTS
We first examined the effects of PGN and the Th2 cy-
tokines IL-4 and IL-13 on the release of eotaxin from
human corneal fibroblasts. The cells were cultured
for 24 h either with various concentrations of PGN in
the absence or presence of IL-4 or IL-13 (each at 10
ngml) (Fig. 1A) or with various concentrations of IL-
4 (Fig. 1B) or IL-13 (Fig. 1C) in the absence or pres-
ence of PGN (30 μgml). In the absence of IL-4 or IL-
13, PGN induced only a small increase in eotaxin re-
lease, which was statistically significant at concentra-
tions of 1.0 to 30 μgml (Fig. 1A). However, in the
presence of IL-4 or IL-13, PGN exhibited a marked
stimulatory effect on eotaxin release that was concen-
tration dependent and maximal at 30 μgml. Simi-
larly, in the absence of PGN, IL-4 (Fig. 1B) or IL-13
(Fig. 1C) induced relatively small increases in eotaxin
release, consistent with our previous observations.3
However, in the presence of PGN, the stimulatory ef-
fects of IL-4 or IL-13 on eotaxin release were mark-
edly potentiated. The time course of eotaxin release
by corneal fibroblasts incubated with the combination
of PGN and either IL-4 or IL-13 was characterized by
a delay of -12 h and a subsequent linear phase for up
Eotaxin and VCAM-1 in Corneal Fibroblast
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Fig.　3　Effects of PGN, IL-4, and IL-13 on the abundance of
eotaxin mRNA in corneal fi broblasts. Cells were cultured for 
6 h with IL-4 or IL-13 (each at 10 ng/ml) in the absence (open
bars) or presence (closed bars) of PGN (30 μg/ml), after
which total RNA was isolated from the cells and the amount 
of eotaxin mRNA was determined by quantitative RT-PCR
analysis. Data were normalized on the basis of the abun-
dance of GAPDH mRNA, are expressed in arbitrary units,
and are means +_ SEM of values from four separate experi-
ments. *p < 0.0001 (Dunnett’s test) versus the corresponding 
value for cells incubated in the absence of cytokine.
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to 72 h (Fig. 1D).
We next examined the specificity of this synergis-
tic effect of IL-4 or IL-13 with PGN on eotaxin release
by corneal fibroblasts. Among the Th2 cytokines
tested, only IL-4 and IL-13, not IL-5 or IL-10, stimu-
lated eotaxin release either alone or synergistically
with PGN (Fig. 2A). To determine whether the syner-
gistic action of PGN and either IL-4 or IL-13 was spe-
cific to eotaxin, we also investigated the effects of
these mediators on the release of another chemokine
for neutrophils, IL-8 (CXCL8). None of the Th2 cy-
tokines tested alone was found to affect IL-8 produc-
tion, whereas PGN stimulated IL-8 release by corneal
fibroblasts (Fig. 2B); this effect of PGN was not po-
tentiated by IL-4, IL-13, or any of the other Th2 cy-
tokines.
We also examined the effects of PGN and Th2 cy-
tokines on eotaxin and IL-8 release by human dermal
fibroblasts. Whereas IL-4, IL-13, or PGN alone in-
duced small increases in the extent of eotaxin re-
lease, the combination of PGN with either IL-4 or IL-
13 resulted in a synergistic increase in eotaxin re-
lease by these cells (Fig. 2C). Again, as for corneal fi-
broblasts, the production of IL-8 by skin fibroblasts
was stimulated only by PGN, not by any of the Th2
cytokines tested (Fig. 2D).
EFFECTS OF PGN, IL-4, AND IL-13 ON THE
ABUNDANCE OF EOTAXIN mRNA IN FIBRO-
BLASTS
We next investigated the effects of PGN, IL-4, and IL-
13 on the abundance of eotaxin mRNA in corneal fi-
broblasts. Cells were cultured for 6 h in the absence
or presence of cytokine (10 ngml) and PGN (30 μg
ml), after which the amount of eotaxin mRNA in cell
lysates was determined by RT and real-time PCR
analysis. Whereas PGN, IL-4, and IL-13 each induced
small increases in the amount of eotaxin mRNA, the
abundance of this transcript was synergistically in-
creased by simultaneous exposure of the cells to the
combination of PGN and either IL-4 or IL-13 (Fig. 3).
Similar results were obtained for the effects of these
agents on the amount of eotaxin mRNA in skin fibro-
blasts (data not shown).
EFFECTS OF PGN AND Th2 CYTOKINES ON
THE EXPRESSION OF ADHESION MOLECULES
IN CORNEAL FIBROBLASTS
We examined the effects of PGN, IL-4, and IL-13 on
the expression of adhesion molecules in corneal fi-
broblasts. The cells were cultured for 24 h with PGN
or Th2 cytokines, after which the expression of
VCAM-1 and ICAM-1 was measured by in situ whole-
cell ELISA (Fig. 4). In the absence of IL-4 or IL-13,
PGN induced only a small increase in VCAM-1 ex-
pression that was statistically significant at concentra-
tions of 1.0 to 100 μgml. In the presence of IL-4 or
IL-13, however, PGN markedly potentiated the stimu-
latory effects of IL-4 or IL-13 on VCAM-1 expression
in a concentration-dependent manner, with the maxi-
mal potentiation apparent at 1.0 μgml (Fig. 4A).
Similarly, IL-4 and IL-13 each potentiated the effect of
PGN on VCAM-1 expression in a concentration-
dependent manner (data not shown). Whereas PGN,
IL-4, or IL-13 induced only small increases in the
amount of VCAM-1 mRNA in corneal fibroblasts, the
combination of PGN and either IL-4 or IL-13 elicited a
synergistic up-regulation of this transcript (Fig. 4B).
Among Th2 cytokines examined, only IL-4 and IL-13,
not IL-5 or IL-10, exhibited a stimulatory effect on
VCAM-1 expression (Fig. 4C). ICAM-1 was constitu-
tively expressed on cell surface of corneal fibroblasts
in unstimulated condition. PGN by itself induced an
approximately two-fold increase in the expression of
ICAM-1. However, none of these four Th2 cytokines
affected ICAM-1 expression in corneal fibroblasts re-
gardless of the stimulation with PGN (Fig. 4D).
EFFECTS OF PGN ON NF-κB ACTIVITY IN COR-
NEAL FIBROBLASTS
The IκB-α-NF-κB pathway plays a key role in induc-
tion of eotaxin and VCAM-1 gene expression in sev-
eral cell types.25,26 We therefore examined the possi-
ble effects of PGN on this signaling pathway in cor-
neal fibroblasts by monitoring the degradation of IκB-
Fukuda K et al.
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Fig.　4　Effects of PGN, IL-4, and IL-13 on the expression of adhesion molecules in corneal fi broblasts. (A) Cells were cul-
tured for 24 h with the indicated concentrations of PGN in the absence (circles) or presence of IL-4 (closed triangles) or IL-13 
(open triangles), each at a concentration of 10 ng/ml, after which the expression of VCAM-1 was examined by in situ whole-
cell ELISA. (B) Cells were cultured for 6 h with IL-4 or IL-13 (each at 10 ng/ml) in the absence (open bars) or presence 
(closed bars) of PGN (30 μg/ml). Total RNA was then isolated and the amount of VCAM-1 mRNA was determined by quanti-
tative RT-PCR analysis. Data were normalized on the basis of the abundance of GAPDH mRNA and are expressed in arbi-
trary units. (C, D) Cells were incubated for 24 h with the indicated Th2 cytokines (10 ng/ml) in the absence (open bars) or 
presence (closed bars) of PGN (30 μg/ml), after which the expression of VCAM-1 (C) or ICAM-1 (D) was examined by in situ 
whole-cell ELISA. All data are means +_ SEM of values from four separate experiments. *p < 0.01 (Dunnett’s test) versus the 
corresponding value for cells incubated in the absence of cytokine or PGN.
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α as well as the nuclear translocation and DNA bind-
ing activity of NF-κB. Exposure of cells to PGN (30
μgml) induced degradation of IκB-α in a time-
dependent manner (Fig. 5A); the decrease in the
amount of IκB-α was first apparent at 10 min and was
maximal at 60 min, after which the abundance of this
protein gradually increased up to 4 h after the onset
of stimulation. Immunofluorescence analysis revealed
that the p65 subunit of NF-κB was located predomi-
nantly in the cytoplasm of corneal fibroblasts under
basal conditions (Fig. 5B), consistent with our previ-
ous observations.22 No immunofluorescence was ap-
parent in cells stained with normal rabbit IgG as a
negative control (data not shown). Treatment of cells
with PGN (30 μgml) resulted in translocation of NF-
κB to the nucleus in a time-dependent manner;
translocation was first detected at 10 min and was
maximal at 60 min (Fig. 5C) after the onset of stimu-
lation. Measurement of the binding of the p65
subunit of NF-κB to an oligonucleotide containing the
consensus binding site revealed that exposure of cor-
neal fibroblasts to PGN (30 μgml) for 60 min re-
sulted in a pronounced increased in the DNA binding
activity of p65 present in nuclear extracts (Fig. 5D).
This effect was similar to that observed with TNF-α
(10 ngml, data not shown), a classical activator of
NF-κB signaling. The specificity of p65 binding was
demonstrated by its inhibition with free wild-type oli-
gonucleotide but not with an oligonucleotide in which
the binding site is mutated (Fig. 5D). These various
observations thus showed that PGN activates the NF-
κB signaling pathway in human corneal fibroblasts.
To confirm the role of NF-κB activation in the
stimulation of eotaxin release by PGN, we examined
the effects of two inhibitors of NF-κB signaling,
PDTC and TPCK, on PGN-induced eotaxin release in
corneal fibroblasts. Oxygen radicals have been impli-
cated in the mechanism of NF-κB activation, and anti-
oxidants such as PDTC have been shown to block
this process in several cell lines.27 TPCK blocks NF-
κB activation by preventing the degradation of IκB
and the translocation of NF-κB to the nucleus.28
PDTC (30 μM) and TPCK (3 μM) each inhibited eo-
taxin release induced by PGN but not that elicited by
IL-4 or IL-13 (Fig. 6). Furthermore, the synergistic in-
crease in eotaxin release induced by PGN and either
IL-4 or IL-13 was inhibited by PDTC or TPCK. These
findings thus suggest that the activation of NF-κB
plays a major role in the induction of eotaxin release
by PGN in corneal fibroblasts.
DISCUSSION
We have shown that PGN of S. aureus induces eo-
taxin production in a synergistic manner with the Th2
cytokines IL-4 or IL-13 in human corneal and dermal
fibroblasts. Given that both the up-regulation of Th2
cytokines and a high rate of S. aureus colonization of
the skin and ocular surface are associated with AKC
and atopic dermatitis,29 our data suggest that the in-
nate immune response to bacterial infection and the
adaptive immune response mediated by IL-4 or IL-13
may together promote tissue eosinophilia through
the intermediary of tissue-resident fibroblasts.
In a mouse model of allergic conjunctivitis, inocula-
tion of S. aureus markedly accelerated Th2-type im-
mune responses and accelerates experimental aller-
gic conjunctivitis including tissue eosinophilia, higher
levels of IgE in serum.30 However, we have also dem-
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Fig.　5　Effect of PGN on NF-κB signaling in corneal fi bro-
blasts. (A) Cells were incubated for the indicated times with 
PGN (30 μg/ml), lysed, and subjected to immunoblot analy-
sis with Abs to IκB-α. (B, C) Cells were incubated in the ab-
sence (B) or presence (C) of PGN (30 μg/ml) for 60 min, 
fi xed, and subjected to immunofl uorescence analysis with 
Abs to the p65 subunit of NF-κB. Scale bar, 50 μm. Data in 
(A) through (C) are representative of three independent ex-
periments. (D) Cells were incubated in the absence or pres-
ence of PGN (30 μg/ml) for 1 h, after which nuclear extracts 
were prepared and assayed for the DNA binding activity of 
the p65 subunit of NF-κB with a colorimetric assay. The 
specifi city of binding was assessed on the basis of competi-
tion with excess wild-type or mutated oligonucleotide (ODN). 
Data are means +_ SEM of values from four separate experi-
ments. *p < 0.0001 (Dunnett’s test) versus control (no PGN).
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Fig.　6　Effects of NF-κB inhibitors on eotaxin release in-
duced by PGN and Th2 cytokines in corneal fi broblasts. 
Cells were preincubated for 1 h in the absence or presence 
of PDTC (30 μM) or TPCK (3 μM) and were then incubated 
for 24 h in the additional absence or presence of PGN (30 
μg/ml), IL-4 (10 ng/ml), or IL-13 (10 ng/ml), as indicated. The 
concentration of eotaxin in culture supernatants was then 
measured by ELISA. Data are means +_ SEM of values from 
four separate experiments. *p < 0.01 (Dunnett’s test) versus 
the corresponding value for cells incubated without inhibitor.
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onstrated that systemic treatment with Pam3CSK4, a
TLR2 agonist, suppressed eosinophil infiltration into
the conjunctiva in a mouse model of allergic conjunc-
tivitis.31 In a mouse model of allergic asthma, the hu-
moral and cellular immune responses, including
eosinophilia, were more marked and Th2 biased in
mice immunized intranasally with both ovalbumin
and PGN than in those immunized with ovalbumin
alone.32 Similarly, exposure to a synthetic ligand of
TLR2 promoted the Th2 response and eosinophil in-
filtration induced by allergen in this same model.33
However, activation of TLR2 immediately before in-
tranasal allergen challenge was found to reduce aller-
gic airway inflammation in the mouse model of
asthma,34 and a TLR2 agonist decreased established
allergic airway inflammation by promoting a Th1 re-
sponse.35 Intradermal injection of cell wall compo-
nents of S. aureus in mice induced localized inflam-
mation that was reminiscent of atopic dermatitis and
characterized by the infiltration of mast cells, eosino-
phils, and mononuclear cells. PGN from S. aureus
also stimulated the production of Th2 cytokines by
and degranulation of mast cells in a TLR2-dependent
manner, and intradermal injection of PGN induced
vasodilation and inflammation in mouse skin.36
Whether TLR2 signaling activates a Th1 or Th2 re-
sponse thus likely depends on the dose, timing of ad-
ministration, and nature of TLR2 agonists and the ge-
netic background of the host. Our results showing
that the combination of PGN and the Th2 cytokines
IL-4 or IL-13 synergistically induces eotaxin release
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by tissue-resident fibroblasts suggest that the con-
comitant local presence of these factors might trigger
tissue eosinophilia without the participation of other
immune cells.
The development of sight-threatening corneal le-
sions secondary to severe allergic inflammation of the
conjunctiva is the most serious complication of ocular
allergy.37 The expression of bioactive molecules,
such as eotaxin and adhesion molecules, by corneal
fibroblasts likely contributes to the formation of cor-
neal lesions by promoting the local infiltration, activa-
tion, and survival of eosinophils.14,15 Knowledge of
the regulation of eotaxin synthesis by corneal fibro-
blasts is thus important for an understanding of the
pathogenesis of corneal lesions and for the develop-
ment of potential new treatments for severe ocular al-
lergy. We have previously shown that concomitant
stimulation with proinflammatory cytokines (TNF-α
or IL-1) and Th2 cytokines (IL-4 or IL-13) synergisti-
cally increases eotaxin production by corneal fibro-
blasts.3,15 In addition, TGF-β or oncostatin-M syner-
gizes with IL-4 or IL-13 to increase eotaxin synthesis
by airway fibroblasts.38,39 We have now shown that
the bacterial component PGN also synergistically in-
creases eotaxin synthesis with the Th2 cytokines IL-4
or IL-13 in corneal fibroblasts, and that this effect is
mediated by activation of NF-κB. Putative binding
sites for NF-κB and STAT6 overlap in the eotaxin
gene promoter, and these two transcription factors
are thought to mediate the synergistic effect of IL-13
or IL-4 with IL-1β on eotaxin gene expression in epi-
thelial cells and fibroblasts.25,40 In addition to the di-
rect effects of PGN on NF-κB activation, it may be
possible that PGN also have indirect effects on the in-
crease of eotaxin synthesis thorough the production
of TNF-α or IL-1 in an autocrine or paracrine manner.
Adhesion molecules are another important deter-
minant of eosinophil infiltration into tissue. The role
of VCAM-1 in the infiltration of inflammatory cells ap-
pears to be selective for eosinophils, given that its
ligand VLA-4 is expressed on the surface of eosino-
phils but not on neutrophils, whereas LFA-1, the
ligand for ICAM-1, is expressed on the surface of
both eosinophils and neutrophils.6 In addition,
VCAM-1 augments the function and survival of
eosinophils.41 IL-4 selectively regulates the expres-
sion of VCAM-1 on human endothelial cells.6 We
have also previously shown that IL-4 and IL-13 each
act synergistically with TNF-α to increase the expres-
sion of VCAM-1, but not that of ICAM-1, in corneal fi-
broblasts.21,42 We have now shown that PGN acts
synergistically with IL-4 or IL-13 to increase the ex-
pression of VCAM-1 in corneal fibroblasts, suggest-
ing that PGN may play an important role in eosino-
phil infiltration by up-regulating the expression of
both a chemokine (eotaxin) and an adhesion mole-
cule (VCAM-1).
In conclusion, our results provide evidence for a
specific and substantial interaction between the in-
nate immune system and the Th2 immune system.
Eotaxin and VCAM-1 play important roles as a
chemokine and adhesion molecule, respectively, in
the induction and maintenance of allergic inflamma-
tion by promoting the infiltration of eosinophils. Al-
though increased tissue eosinophilia by the infection
of S. aureus in a murine allergic conjunctivitis has
been attributed to accelerated Th2-type immune re-
sponses,30 our report provides the possibility, for the
first time, that the expression of chemokines and ad-
hesion molecules by S. aureus-stimulated fibroblasts
contributes to eosinophilic inflammation in AKC and
atopic dermatitis. Given that S. aureus colonizes the
skin and ocular surface in most atopic patients, our
data suggest that infection with this bacterium in the
atopic Th2 background might markedly enhance tis-
sue eosinophilia through up-regulation of the expres-
sion of eotaxin and VCAM-1 by tissue-resident fibro-
blasts. Knowledge of the mechanisms of interaction
between infection and allergy may eventually lead to
an increased understanding of allergic diseases such
as AKC and atopic dermatitis.
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